Founded in 2007, Klea Holding is a group focused on acquiring, developing and digitizing companies in various sectors to maximize their growth and value. Through its "scaling industries of the future" identity, Klea Holding draws on its successful experience in developing Smart Salem, the first network of digitalized medical analysis centers accredited by the Dubai Ministry of Health (DHA) in the United Arab Emirates, its joint venture Smart Health, dedicated to the roll-out of digital medical testing centres in Saudi Arabia; and Klea Pharmaceuticals, a subsidiary dedicated to the commercialisation of a portfolio of licensed medicines in the Middle East and Africa.

Employees

128

Sector

Healthcare Facilities & Services

More about the company

Quotes

Date	Price	Change	Volume
14/07/26	EUR 0.1790	+1.47%	50,797
10/07/26	EUR 0.1764	+0.23%	102,746
09/07/26	EUR 0.1760	-0.56%	171,021
08/07/26	EUR 0.1770	-1.67%	131,903
07/07/26	EUR 0.1800	-0.44%	38,468

Real-time Euronext Paris

More quotes

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

Market Closed - Euronext Paris Other stock markets 01:55:00 14/07/26 am AEST			After hours 04:18:41 am
0.1790 ^EUR	+1.47%		0.1780	-0.56%

12/06	Klea Holding SA Announces the Launch of Its New Subsidiary, Klea Pharmaceuticals	CI
11/06	Klea Launches Medicine Distribution Business for Middle East, Africa	MT

Market Cap	54.15M 61.74M 50.16M 46.15M 87.29M 5.91B 88.99M 598M 234M 2.9B 232M 227M 10.02B	P/E 2024	44.3x	P/E 2025	31.3x
Enterprise Value	54.28M 61.88M 50.27M 46.26M 87.49M 5.92B 89.19M 599M 235M 2.91B 232M 227M 10.04B	EV / Sales 2024	3.3x	EV / Sales 2025	3.04x
Free-Float	99.83%	Yield 2024 *	-	Yield 2025	-

12/06	Klea Holding SA Announces the Launch of Its New Subsidiary, Klea Pharmaceuticals	CI
11/06	Klea Launches Medicine Distribution Business for Middle East, Africa	MT
11/06	Klea Holding announces the launch of its new subsidiary
24/04	Klea Holding SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
01/04	Klea Holding Establishes Klea Pharmaceuticals and Expands Healthcare Operations in Middle East and Africa	CI
01/04	Klea Holding SA acquired New Licences and Pharmaceutical Assets for AED 8.5 million.	CI
20/01	Klea Holding Increases Annual Revenue by 28%
19/01	Klea Holding SA Reports Unaudited Consolidated Sales Results for the Year Ended December 31, 2025	CI
19/01	Klea Holding SA to Open First Digital Medical Centre in Saudi Arabia in March/April 2026	CI
27/10/25	Klea Holding Strengthens Its Presence in Dubai with Its First Strategic Real Estate Investment in the Lumena Alta Project	CI
27/10/25	Klea Holding Buys Office Space at Skyscraper Project in Dubai	MT
19/09/25	Klea Holding SA Reports Earnings Results for the Half Year Ended June 30, 2025	CI
19/08/25	Klea Holding SA commences an Equity Buyback Plan for 30,751,431 shares, representing 10% of its issued share capital for ?46.13 million, under the authorization approved on June 10, 2025.	CI

11/06	Klea Holding : Klea Pharmaceuticals launch its business with a strong partner	AT
24/04	Klea : reports record results in 2025 and demonstrates remarkable resilience in Q1 2026	PU
24/04	Klea Holding : Klea Holding reports record results in 2025 and demonstrates remarkable resilience in Q1 2026	AT
01/04	Klea Holding : Klea Holding is accelerating its diversification into the healthcare sector with the creation of Klea Pharmaceuticals	AT
19/01	Klea Holding : Klea Holding reports profitable growth of 34% in turnover in 2025 at constant exchange rates	AT

Klea Holding Stock

Stocks

ALKLH

FR0013481835

Healthcare Facilities & Services

Valuation: Klea Holding

Chart: Klea Holding

Latest news : Klea Holding

Analysts' recommendations: Klea Holding

Press Releases: Klea Holding

News in other languages: Klea Holding

Quotes and Performance

Course Extremes

Managers and Directors: Klea Holding

Latest insider transactions

Other Healthcare Facilities & Services

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

02:01am	Klea Holding : Déclaration des transactions sur actions propres
07/07	Klea Holding : Déclaration des transactions sur actions propres
30/06	Klea Holding : Déclaration des transactions sur actions propres
13/06	Klea Holding : Déclaration des transactions sur actions propres
11/06	Bourse : J-1 avant SpaceX, Oracle à la peine, contrat pour Airbus

1 day	+1.47%
1 week	-1.00%
Current month	-2.40%
1 month	-6.77%
3 months	+0.79%
6 months	-21.15%
Current year	-18.26%

1 week	0.17	0.18
1 month	0.17	0.19
Current year	0.15	0.25
1 year	0.15	0.31
3 years	0.15	0.52
5 years	0.08	0.59
10 years	0.08	172.4

Manager	Title	Age	Since
Clement Pacaud CEO	Chief Executive Officer	36	22/01/2024
Jérôme Fabreguettes-Leib IRC	Investor Relations Contact	-	-
Thomas Picquette CEO	Chief Executive Officer	-	01/04/2022

Director	Title	Age	Since
Guillaume Bremond CHM	Chairman	-	-
Anne Gaignard BRD	Director/Board Member	-	01/04/2022
Paul Amsellem BRD	Director/Board Member	51	14/06/2023

Date	Insider	Type	Quantity	% Market Cap.
11/03	Raphael Smila	Buy	95,000	0.0309%
11/03	Raphael Smila	Buy	40,000	0.0130%
11/03	Raphael Smila	Buy	10,000	0.0033%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KLEA HOLDING	+1.47%	-1.00%	-0.56%	-64.69%	61.91M
CVS HEALTH CORPORATION	+1.84%	+3.99%	+64.93%	+49.05%	133B
HCA HEALTHCARE, INC.	-3.26%	-5.61%	+3.47%	+33.01%	90.2B
FRESENIUS SE & CO. KGAA	-2.07%	-3.50%	-0.69%	+60.66%	27.41B
QUEST DIAGNOSTICS INCORPORATED	+0.43%	-2.19%	+24.00%	+48.31%	22.96B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+0.19%	-1.06%	-18.79%	-27.69%	20.02B
TENET HEALTHCARE CORPORATION	-4.24%	-5.18%	+10.00%	+136.32%	17.59B
REDE D'OR SÃO LUIZ S.A.	-1.28%	+1.60%	+6.34%	+10.09%	15.5B
DAVITA INC.	+1.09%	-0.36%	+63.77%	+127.45%	14.95B
FRESENIUS MEDICAL CARE AG	+2.41%	+4.25%	-7.64%	-7.83%	12.75B
Average	-0.46%	-0.56%	+14.48%	+36.47%	35.43B
Weighted average by Cap.	-0.48%	-0.66%	+28.87%	+45.35%

	2024	2025
Net sales	17.26M 19.68M 15.99M 14.71M 27.82M 1.88B 28.36M 191M 74.73M 925M 73.89M 72.28M 3.19B	22.17M 25.27M 20.53M 18.89M 35.73M 2.42B 36.42M 245M 95.97M 1.19B 94.9M 92.82M 4.1B
Net income	1.4M 1.6M 1.3M 1.2M 2.26M 153M 2.31M 15.51M 6.08M 75.29M 6.02M 5.88M 260M	2.28M 2.6M 2.11M 1.94M 3.68M 249M 3.75M 25.18M 9.88M 122M 9.77M 9.55M 422M
Net Debt	2.58M 2.94M 2.38M 2.19M 4.15M 281M 4.23M 28.43M 11.15M 138M 11.02M 10.78M 477M	125K 143K 116K 107K 201K 13.64M 205K 1.38M 541K 6.7M 535K 523K 23.13M